Annual Accounts Payable
$3.77 M
+$2.33 M+160.68%
31 December 2023
Summary:
Cidara Therapeutics annual accounts payable is currently $3.77 million, with the most recent change of +$2.33 million (+160.68%) on 31 December 2023. During the last 3 years, it has fallen by -$796.00 thousand (-17.43%). CDTX annual accounts payable is now -17.43% below its all-time high of $4.57 million, reached on 31 December 2020.CDTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$2.97 M
+$679.00 K+29.68%
30 September 2024
Summary:
Cidara Therapeutics quarterly accounts payable is currently $2.97 million, with the most recent change of +$679.00 thousand (+29.68%) on 30 September 2024. Over the past year, it has dropped by -$694.00 thousand (-18.96%). CDTX quarterly accounts payable is now -41.31% below its all-time high of $5.05 million, reached on 31 March 2024.CDTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CDTX Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +160.7% | -19.0% |
| 3 y3 years | -17.4% | -8.5% |
| 5 y5 years | +32.5% | +10.8% |
CDTX Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -17.4% | +189.9% | -41.3% | +128.1% |
| 5 y | 5 years | -17.4% | +189.9% | -41.3% | +128.1% |
| alltime | all time | -17.4% | >+9999.0% | -41.3% | +247.4% |
Cidara Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.97 M(+29.7%) |
| June 2024 | - | $2.29 M(-54.7%) |
| Mar 2024 | - | $5.05 M(+34.0%) |
| Dec 2023 | $3.77 M(+160.7%) | $3.77 M(+3.0%) |
| Sept 2023 | - | $3.66 M(+92.8%) |
| June 2023 | - | $1.90 M(-52.3%) |
| Mar 2023 | - | $3.98 M(+175.1%) |
| Dec 2022 | $1.45 M(+11.2%) | $1.45 M(-65.9%) |
| Sept 2022 | - | $4.24 M(+37.3%) |
| June 2022 | - | $3.09 M(+8.0%) |
| Mar 2022 | - | $2.86 M(+119.9%) |
| Dec 2021 | $1.30 M(-71.5%) | $1.30 M(-59.9%) |
| Sept 2021 | - | $3.24 M(+25.3%) |
| June 2021 | - | $2.59 M(-19.5%) |
| Mar 2021 | - | $3.21 M(-29.6%) |
| Dec 2020 | $4.57 M(+142.1%) | $4.57 M(+125.7%) |
| Sept 2020 | - | $2.02 M(-31.0%) |
| June 2020 | - | $2.93 M(+14.6%) |
| Mar 2020 | - | $2.56 M(+35.7%) |
| Dec 2019 | $1.89 M | $1.89 M(-29.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | $2.68 M(+49.9%) |
| June 2019 | - | $1.79 M(+4.3%) |
| Mar 2019 | - | $1.71 M(-39.8%) |
| Dec 2018 | $2.85 M(+9.9%) | $2.85 M(+16.7%) |
| Sept 2018 | - | $2.44 M(-6.6%) |
| June 2018 | - | $2.61 M(-12.9%) |
| Mar 2018 | - | $3.00 M(+15.8%) |
| Dec 2017 | $2.59 M(-11.0%) | $2.59 M(+45.8%) |
| Sept 2017 | - | $1.78 M(-63.1%) |
| June 2017 | - | $4.82 M(+151.9%) |
| Mar 2017 | - | $1.91 M(-34.3%) |
| Dec 2016 | $2.91 M(-6.0%) | $2.91 M(-1.6%) |
| Sept 2016 | - | $2.96 M(+94.9%) |
| June 2016 | - | $1.52 M(+19.8%) |
| Mar 2016 | - | $1.27 M(-59.1%) |
| Dec 2015 | $3.10 M(+163.0%) | $3.10 M(+131.3%) |
| Sept 2015 | - | $1.34 M(+56.7%) |
| June 2015 | - | $854.00 K(-49.6%) |
| Mar 2015 | - | $1.70 M(+44.1%) |
| Dec 2014 | $1.18 M(+3578.1%) | $1.18 M |
| Dec 2013 | $32.00 K | - |
FAQ
- What is Cidara Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Cidara Therapeutics?
- What is Cidara Therapeutics annual accounts payable year-on-year change?
- What is Cidara Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Cidara Therapeutics?
- What is Cidara Therapeutics quarterly accounts payable year-on-year change?
What is Cidara Therapeutics annual accounts payable?
The current annual accounts payable of CDTX is $3.77 M
What is the all time high annual accounts payable for Cidara Therapeutics?
Cidara Therapeutics all-time high annual accounts payable is $4.57 M
What is Cidara Therapeutics annual accounts payable year-on-year change?
Over the past year, CDTX annual accounts payable has changed by +$2.33 M (+160.68%)
What is Cidara Therapeutics quarterly accounts payable?
The current quarterly accounts payable of CDTX is $2.97 M
What is the all time high quarterly accounts payable for Cidara Therapeutics?
Cidara Therapeutics all-time high quarterly accounts payable is $5.05 M
What is Cidara Therapeutics quarterly accounts payable year-on-year change?
Over the past year, CDTX quarterly accounts payable has changed by -$694.00 K (-18.96%)